Similar articles

• [Pancreatic cancer (adenocarcinoma). Diagnosis, clinical course and prognosis, therapeutic principles].

  Lacaine F. Lacaine F. Rev Prat. 1990 Jan 11;40(2):173-6. Rev Prat. 1990. PMID: 2300777 French. No abstract available.
• [S3-Guidelines "Exocrine pancreatic cancer" 2007].

  Adler G, Seufferlein T, Bischoff SC, Brambs HJ, Feuerbach S, Grabenbauer G, Hahn S, Heinemann V, Hohenberger W, Langrehr JM, Lutz MP, Micke O, Neuhaus H, Neuhaus P, Oettle H, Schlag PM, Schmid R, Schmiegel W, Schlottmann K, Werner J, Wiedenmann B, Kopp I. Adler G, et al. Z Gastroenterol. 2007 Jun;45(6):487-523. doi: 10.1055/s-2007-963224. Z Gastroenterol. 2007. PMID: 17607616 German. No abstract available.
• Treatment of pancreatic adenocarcinoma: a European perspective.

  Gouma DJ, Busch OR, van Gulik TM. Gouma DJ, et al. Surg Oncol Clin N Am. 2008 Jul;17(3):569-86, ix. doi: 10.1016/j.soc.2008.02.005. Surg Oncol Clin N Am. 2008. PMID: 18486884 Review.
• [Physiopathology and therapeutic prospects of cancer of the pancreas].

  Bournet B, Buscail L. Bournet B, et al. Rev Infirm. 2011 Mar;(169):18-20. Rev Infirm. 2011. PMID: 21469365 French. No abstract available.
• [Serum tumor markers at exocrine adenocarcinoma of pancreas].

  Holubec L, Finek J, Topolcan O, Svobodová S. Holubec L, et al. Cas Lek Cesk. 2005;144(2):86-8; discussion 89. Cas Lek Cesk. 2005. PMID: 15807292 Review. Czech.